Cargando…

Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis

BACKGROUND: Essential hypertension is one of the most common chronic diseases, as well as one of the leading risk factors for cardio-cerebrovascular diseases. Tianma Gouteng decoction has been commonly used in clinical practice for patients with essential hypertension. It is important to update the...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Benjian, Wang, Yuanping, He, Zhuogen, Wang, Dawei, Yan, Xia, Xie, Pingchang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841972/
https://www.ncbi.nlm.nih.gov/pubmed/29465596
http://dx.doi.org/10.1097/MD.0000000000009972
_version_ 1783304830494703616
author Chen, Benjian
Wang, Yuanping
He, Zhuogen
Wang, Dawei
Yan, Xia
Xie, Pingchang
author_facet Chen, Benjian
Wang, Yuanping
He, Zhuogen
Wang, Dawei
Yan, Xia
Xie, Pingchang
author_sort Chen, Benjian
collection PubMed
description BACKGROUND: Essential hypertension is one of the most common chronic diseases, as well as one of the leading risk factors for cardio-cerebrovascular diseases. Tianma Gouteng decoction has been commonly used in clinical practice for patients with essential hypertension. It is important to update the search and evaluation to provide the best available evidence for essential hypertension. Here, we provide a protocol to evaluate the efficacy and safety of Tianma Gouteng decoction (TGD) for essential hypertension. METHODS: Retrieve literature on the TGD treatment for essential hypertension in the databases including PubMed, Cochrane Library, EMBASE, Chinese Biomedical database (CBM), Chinese National Knowledge Infrastructure (CNKI), Wanfang database, and Chinese Science and Technology Periodical database (VIP) on computer. The literature to be collected will be those published from the time when the respective databases were established to January 2018. The therapeutic effects according to the blood pressure (BP) will be accepted as the primary outcomes. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a meta-analysis is allowed. RESULTS: This study will provide a high-quality synthesis of current evidence of TGD for essential hypertension from several aspects including BP, life quality, heart rate, and adverse events. CONCLUSION: The conclusion of our systematic review will provide evidence to judge whether TGD is an effective intervention for patient with essential hypertension. PROSPERO REGISTRATION NUMBER: PROSPERO CRD 42018082319.
format Online
Article
Text
id pubmed-5841972
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Wolters Kluwer Health
record_format MEDLINE/PubMed
spelling pubmed-58419722018-03-13 Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis Chen, Benjian Wang, Yuanping He, Zhuogen Wang, Dawei Yan, Xia Xie, Pingchang Medicine (Baltimore) 3800 BACKGROUND: Essential hypertension is one of the most common chronic diseases, as well as one of the leading risk factors for cardio-cerebrovascular diseases. Tianma Gouteng decoction has been commonly used in clinical practice for patients with essential hypertension. It is important to update the search and evaluation to provide the best available evidence for essential hypertension. Here, we provide a protocol to evaluate the efficacy and safety of Tianma Gouteng decoction (TGD) for essential hypertension. METHODS: Retrieve literature on the TGD treatment for essential hypertension in the databases including PubMed, Cochrane Library, EMBASE, Chinese Biomedical database (CBM), Chinese National Knowledge Infrastructure (CNKI), Wanfang database, and Chinese Science and Technology Periodical database (VIP) on computer. The literature to be collected will be those published from the time when the respective databases were established to January 2018. The therapeutic effects according to the blood pressure (BP) will be accepted as the primary outcomes. We will use RevMan V.5.3 software as well to compute the data synthesis carefully when a meta-analysis is allowed. RESULTS: This study will provide a high-quality synthesis of current evidence of TGD for essential hypertension from several aspects including BP, life quality, heart rate, and adverse events. CONCLUSION: The conclusion of our systematic review will provide evidence to judge whether TGD is an effective intervention for patient with essential hypertension. PROSPERO REGISTRATION NUMBER: PROSPERO CRD 42018082319. Wolters Kluwer Health 2018-02-23 /pmc/articles/PMC5841972/ /pubmed/29465596 http://dx.doi.org/10.1097/MD.0000000000009972 Text en Copyright © 2018 the Author(s). Published by Wolters Kluwer Health, Inc. http://creativecommons.org/licenses/by/4.0 This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. http://creativecommons.org/licenses/by/4.0
spellingShingle 3800
Chen, Benjian
Wang, Yuanping
He, Zhuogen
Wang, Dawei
Yan, Xia
Xie, Pingchang
Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title_full Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title_fullStr Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title_full_unstemmed Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title_short Tianma Gouteng decoction for essential hypertension: Protocol for a systematic review and meta-analysis
title_sort tianma gouteng decoction for essential hypertension: protocol for a systematic review and meta-analysis
topic 3800
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5841972/
https://www.ncbi.nlm.nih.gov/pubmed/29465596
http://dx.doi.org/10.1097/MD.0000000000009972
work_keys_str_mv AT chenbenjian tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis
AT wangyuanping tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis
AT hezhuogen tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis
AT wangdawei tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis
AT yanxia tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis
AT xiepingchang tianmagoutengdecoctionforessentialhypertensionprotocolforasystematicreviewandmetaanalysis